RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Richard Yanagihara to Gene Products, env

This is a "connection" page, showing publications Richard Yanagihara has written about Gene Products, env.
Connection Strength

0.466
  1. Hoshino H, Nakamura T, Tanaka Y, Miyoshi I, Yanagihara R. Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and melanesian strains of human T cell leukemia/lymphoma virus type I. J Infect Dis. 1993 Dec; 168(6):1368-73.
    View in: PubMed
    Score: 0.122
  2. Lal RB, Rudolph DL, Nerurkar VR, Yanagihara R. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians. Viral Immunol. 1992; 5(4):265-72.
    View in: PubMed
    Score: 0.106
  3. Yanagihara R, Ajdukiewicz AB, Nerurkar VR, Garruto RM, Gajdusek DC. Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification. Jpn J Cancer Res. 1991 Mar; 82(3):240-4.
    View in: PubMed
    Score: 0.100
  4. Nerurkar VR, Song KJ, Bastian IB, Garin B, Franchini G, Yanagihara R. Genotyping of human T cell lymphotropic virus type I using Australo-Melanesian topotype-specific oligonucleotide primer-based polymerase chain reaction: insights into viral evolution and dissemination. J Infect Dis. 1994 Dec; 170(6):1353-60.
    View in: PubMed
    Score: 0.033
  5. Yanagihara R. Geographic-specific genotypes or topotypes of human T-cell lymphotropic virus type I as markers for early and recent migrations of human populations. Adv Virus Res. 1994; 43:147-86.
    View in: PubMed
    Score: 0.031
  6. Sherman MP, Dube S, Spicer TP, Kane TD, Love JL, Saksena NK, Iannone R, Gibbs CJ, Yanagihara R, Dube DK, et al. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia. Cancer Res. 1993 Dec 15; 53(24):6067-73.
    View in: PubMed
    Score: 0.030
  7. Nerurkar VR, Babu PG, Song KJ, Melland RR, Gnanamuthu C, Saraswathi NK, Chandy M, Godec MS, John TJ, Yanagihara R. Sequence analysis of human T cell lymphotropic virus type I strains from southern India: gene amplification and direct sequencing from whole blood blotted onto filter paper. J Gen Virol. 1993 Dec; 74 ( Pt 12):2799-805.
    View in: PubMed
    Score: 0.030
  8. Lal RB, Brodine S, Kazura J, Mbidde-Katonga E, Yanagihara R, Roberts C. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections. J Clin Microbiol. 1992 Feb; 30(2):296-9.
    View in: PubMed
    Score: 0.007
  9. Gessian A, Yanagihara R, Franchini G, Garruto RM, Jenkins CL, Ajdukiewicz AB, Gallo RC, Gajdusek DC. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc Natl Acad Sci U S A. 1991 Sep 01; 88(17):7694-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support